Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (121-130 of 6,821) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|November 29, 2018
FDA approves first new flu drug in 20 yearsAsher Mullard
Nature Biotechnology|May 7, 2016
DNA-encoded drug libraries come of ageAsher Mullard
Nature Reviews. Drug Discovery|November 7, 2020
Carolyn BertozziAsher Mullard
Nature Reviews. Drug Discovery|February 12, 2024
Vertex's non-opioid painkiller passes phase III testsAsher Mullard
Nature Reviews. Drug Discovery|August 16, 2024
FDA approves first TCR-engineered T cell therapy, for rare soft-tissue cancerAsher Mullard
Nature Reviews. Drug Discovery|August 5, 2024
Per-patient approach to calculating drug development costs yields lower estimateAsher Mullard
Nature Reviews. Drug Discovery|March 8, 2024
Shifts in the clinical trial landscapeAsher Mullard
Nature Reviews. Drug Discovery|April 17, 2024
Three-step cures for autoimmune diseases?Asher Mullard
Nature Reviews. Drug Discovery|April 18, 2024
RNA-editing drugs advance into clinical trialsAsher Mullard
Nature Reviews. Drug Discovery|April 9, 2022
Roche's anti-TIGIT drug suffers a phase III cancer setbackAsher Mullard
Pageof 683

Showing results (121-130 of 6,821) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|November 29, 2018
FDA approves first new flu drug in 20 yearsAsher Mullard
Nature Biotechnology|May 7, 2016
DNA-encoded drug libraries come of ageAsher Mullard
Nature Reviews. Drug Discovery|November 7, 2020
Carolyn BertozziAsher Mullard
Nature Reviews. Drug Discovery|February 12, 2024
Vertex's non-opioid painkiller passes phase III testsAsher Mullard
Nature Reviews. Drug Discovery|August 16, 2024
FDA approves first TCR-engineered T cell therapy, for rare soft-tissue cancerAsher Mullard
Nature Reviews. Drug Discovery|August 5, 2024
Per-patient approach to calculating drug development costs yields lower estimateAsher Mullard
Nature Reviews. Drug Discovery|March 8, 2024
Shifts in the clinical trial landscapeAsher Mullard
Nature Reviews. Drug Discovery|April 17, 2024
Three-step cures for autoimmune diseases?Asher Mullard
Nature Reviews. Drug Discovery|April 18, 2024
RNA-editing drugs advance into clinical trialsAsher Mullard
Nature Reviews. Drug Discovery|April 9, 2022
Roche's anti-TIGIT drug suffers a phase III cancer setbackAsher Mullard
Pageof 683